Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-10-28
2009-11-17
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S080000
Reexamination Certificate
active
07618979
ABSTRACT:
Pyridopyrrolizine and pyridoindolizine derivatives are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
REFERENCES:
patent: 4808608 (1989-02-01), Guindon et al.
patent: 5128364 (1992-07-01), Girard et al.
patent: 0 166 591 (1985-06-01), None
patent: 0 441 517 (1991-01-01), None
patent: WO 98/25919 (1998-06-01), None
patent: WO 99/62555 (1999-12-01), None
patent: WO 02/94830 (2002-11-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley.
Dufresne Claude
Leblanc Yves
Roy Patrick
Brown Dianne
Daniel Mark R.
Desai Rita J
Merck Frosst Canada Ltd.
LandOfFree
Pyridopyrrolizine and pyridoindolizine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridopyrrolizine and pyridoindolizine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyrrolizine and pyridoindolizine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4101521